Lv522
900 积分 2026-04-29 加入
SHR-2005, an FcγR-Dependent CD40 Agonistic Antibody with Potent Antitumor Activities and Favorable Safety Profile
1个月前
已完结
Co-blocking TIGIT and PVRIG Using a Novel Bispecific Antibody Enhances Antitumor Immunity
1个月前
已完结
Development of a Tumor-Specific Multivalent CD40 Agonist Antibody FAPxCD40 for Cancer Therapy: Balancing Efficacy and Toxicity
1个月前
已完结
Functional and dysfunctional T regulatory cell states in human tissues in RA and other autoimmune arthritic diseases
1个月前
已完结
Why regulatory T cells fail to control inflammation in rheumatoid arthritis
1个月前
已完结
Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA
1个月前
已关闭
Circular RNA SCMH1 promotes persistent brain repair via N 6-methyladenosine methylation post stroke
2个月前
已完结
uPAR is highly expressed in recurrent glioblastoma and represents a candidate CAR T cell target
2个月前
已完结
In vivo CAR T cell engineering: design principles and open questions
3个月前
已完结
Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer
3个月前
已完结
皖公网安备34019202002308
